Chemed Corp (CHE)

Industry Medical Care Facilities
This stock can be held in an Investment ISA and an Investment Account
Sell

$559.66

Buy

$561.08

arrow-down$-8.57 (-1.51%)

Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services.
Prices updated at 13 May 2025, 17:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.83%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Care Facilities
Chairman
Mr. Spencer S. Lee
CEO
Mr. Kevin J. Mcnamara
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
15,695
Head office
255 East Fifth Street
Cincinnati
United States
45202-4726
mobile
+1 513 762-6690
letter
-
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Dr. Andrea R. Lindell,PhD
Independent Director
0.11m--0.28m-
Mr. George J. Walsh,III
Chairman of the Board
0.28m--0.48m-
Mr. Kevin J. Mcnamara
President, Chief Executive Officer and Director
1.74m--12.77m-
Mr. Patrick P. Grace
Independent Director
0.15m--0.31m-
Mr. Thomas C. Hutton
Director
-----
Mr. Thomas P. Rice
Independent Director
0.12m--0.28m-
Mr. Spencer S. Lee
Executive Vice President; Chairman of the Board and Chief Executive Officer of Roto-Rooter Services Company
0.64m--2.95m-
Mr. John M. Mount, Jr
Independent Director
0.12m--0.28m-
Mr. Nicholas M. Westfall
Executive Vice President; Chief Executive Officer of Vitas
0.67m--5.14m-
Mr. Michael D. Witzeman
Chief Financial Officer, Vice President, Controller and Principal Accounting Officer
0.52m--3.49m-
Mr. Ron DeLyons
Independent Director
0.12m--0.28m-
Mr. Christopher J. Heaney
Independent Director
0.12m--0.28m-
Mr. Brian C. Judkins
Vice President, Secretary and Chief Legal Officer
0.41m--2.63m-
Ms. Eileen P. McCarthy
Independent Director
0.11m--0.28m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc1,669,1210.015425680.15409130 Apr 202511.41
BlackRock Inc1,382,6740.01482-38493-2.70854930 Apr 20259.45
BlackRock Fund Advisors806,1336.34018-9531-30 Apr 20255.51
Kayne Anderson Rudnick Investment Management LLC582,1340.70936-10820-1.82476230 Apr 20253.98
Neuberger Berman Investment Advisers LLC501,5620.2109558091.17175330 Apr 20253.43

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
30 Dec 2024-Mr. Brian C. Judkins519.5075,3281,678--
02 Dec 2024-Mr. Spencer S. Lee--18,222--
27 Nov 2024-Mr. Spencer S. Lee575.62421,35618,287--
25 Nov 2024-Mr. Kevin J. Mcnamara572.771,145,540101,735--
22 Nov 2024-Mr. Spencer S. Lee565.71565,71019,019--
22 Oct 2024-Mr. Kevin J. Mcnamara597.7024,106,436217,487--
22 Oct 2024-Mr. Thomas C. Hutton597.702,703,39720,380--
22 Oct 2024-Mr. Spencer S. Lee597.705,442,05924,542--
22 Oct 2024-Mr. Nicholas M. Westfall597.7010,034,18862,260--
22 Oct 2024-Mr. Michael D Witzeman597.708,006,19243,280--
22 Oct 2024-Mr. Brian C. Judkins597.706,170,05733,373--
26 Sep 2024-Mr. George J. Walsh,III597.47238,9883,046--
26 Sep 2024-Mr. Kevin J. Mcnamara598.811,197,620103,735--
09 Sep 2024-Mr. Nicholas M. Westfall569.35975,2976,109--
04 Sep 2024-Mr. Nicholas M. Westfall586.397,986,6327,822--
04 Sep 2024-Mr. Nicholas M. Westfall471.747,233,18945,472--
04 Sep 2024-Mr. Nicholas M. Westfall471.747,233,18921,442--
21 Aug 2024-Mr. George J. Walsh,III577.95115,5903,446--
16 Aug 2024-Dr. Andrea R. Lindell,PhD571.51474,9255,725--
09 Aug 2024-Mr. Spencer S. Lee413.193,718,71027,611--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.